Titan Pharmaceuticals, Inc. - TTNP

About Gravity Analytica
Recent News
- 04.22.2025 - 8-K - Current report
- 04.22.2025 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition
- 04.16.2025 - 3 - Initial statement of beneficial ownership of securities
- 04.11.2025 - Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
- 04.01.2025 - 8-K - Current report
- 03.20.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 01.08.2025 - 8-K - Current report filing
- 01.03.2025 - 10-Q - Quarterly report pursuant to Section 13 or 15(d)
- 01.03.2025 - 10-Q - Quarterly report pursuant to Section 13 or 15(d)
- 12.06.2024 - 8-K - Current report filing
Recent Filings
- 04.16.2025 - 3 Initial statement of beneficial ownership of securities
- 04.01.2025 - 8-K Current report
- 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
- 01.08.2025 - 8-K Current report
- 01.03.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 12.06.2024 - 8-K Current report
- 11.27.2024 - EX-99.1 EX-99.1
- 11.27.2024 - 8-K Current report